Market Research Report
Diabetic Foot Ulcers Treatment - Global Market Outlook (2019 -2027)
|Published by||Stratistics Market Research Consulting||Product code||951484|
|Published||Content info||130 Pages
Delivery time: 2-3 business days
|Diabetic Foot Ulcers Treatment - Global Market Outlook (2019 -2027)|
|Published: July 1, 2020||Content info: 130 Pages||
According to Stratistics MRC, the Global Diabetic Foot Ulcers Treatment Market is accounted for $4.29 billion in 2019 and is expected to reach $9.33 billion by 2027 growing at a CAGR of 10.2% during the forecast period. Increasing occurrence of chronic diabetes, hastily increasing geriatric population globally and advancements in the field of research are the major factors propelling the market growth. However, the high cost of ulcer management and lack of healthcare facilities are hampering the market growth.
A diabetic foot ulcer treatment is a common situation in diabetic patients, and can be a disabling condition, as well as resulting in amputation of the leg. The major reason for diabetic foot ulcer is neuropathic and vascular changes in diabetes patients, which result in chronic wounds due to minor trauma or pressure. The mortality rate is high because of diabetic foot ulcers, and chances of reappearance of cured foot ulcers are relatively high.
Based on the end user, the hospitals segment is estimated to have a lucrative growth owing to a superior implementation rate of treatment options for diabetic foot ulcers in hospitals, presence of necessary facility trained staff, and growing patient inclination to hospitals owing to excellent policies.
By geography, North America is going to have a lucrative growth during the forecast period due to growing geriatric population, and large patient pool of diabetic patients and well established healthcare facilities and infrastructure in countries in the region. In addition, extended research and development and approval cycles are required due to capital-intensive nature in countries of North America, and this is among some of the major factors projected to drive growth of the market in the region.
Some of the key players profiled in the Diabetic Foot Ulcers Treatment Market include 3M Co., Johnson & Johnson Services, Inc., Medline Industries Inc., Molnlycke Health Care AB, Organogenesis, Inc., Orpyx Medical Technologies Inc., Paul Hartmann AG, and B. Braun Melsungen AG, Cardinal Health, Inc., Coloplast A/S, ConvaTec Group Plc, Essity AB, Hollister, Inc., Integra LifeSciences Corp. and Izun Pharmaceuticals Corp.
Ulcer Types Covered:
End Users Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.